Genetics and genomics research has grown at a bewildering pace in the past 15 years. The techniques of these fields are being applied to a wealth of biological questions and experimental systems. PLOS Genetics reflects the full breadth and interdisciplinary nature of this research by publishing outstanding original contributions in all areas of biology.
PLOS Genetics publishes human studies, as well as research on model organisms—from mice and flies, to plants and bacteria. Our emphasis is on studies of broad interest that provide significant insight into a biological process or processes. Topics include (but are not limited to) gene discovery and function, population genetics, genome projects, comparative and functional genomics, medical genetics, disease biology, evolution, gene expression, complex traits, chromosome biology, and epigenetics.
PLOS Genetics features outstanding primary research articles, occasional Editorials, engaging Interviews and Formal Comments, Viewpoints, Perspectives, and Reviews by invitation.
A list of highly cited articles is available via Google Scholar.
To be considered for publication in PLOS Genetics, any given manuscript must satisfy the following criteria:
High importance to researchers in the field
Broad interest to researchers in genetics and genomics
Substantial evidence for its conclusions
For manuscripts that focus on descriptive genomics, the PLOS Genetics editors are generally most enthusiastic about those that also include innovative theoretical treatment or follow-up experimentation that reveals novel and significant biological insight.
To ensure the fairest and most objective decision-making, the editorial process is run as a partnership between the PLOS Genetics Editors-in-Chief, a team of Section Editors (SEs), and a group of academic experts who act as Associate Editors (AEs). These individuals are leaders in their fields and represent the full breadth of genetics and genomics.
PLOS applies the Creative Commons Attribution (CC BY) license to works we publish. This license was developed to facilitate open access – namely, free immediate access to, and unrestricted reuse of, original works of all types.
Under this license, authors agree to make articles legally available for reuse, without permission or fees, for virtually any purpose. Anyone may copy, distribute, or reuse these articles, as long as the author and original source are properly cited. Read more about our content license.
At PLOS, we believe that research articles should primarily be judged on their individual merits, rather than on the basis of the journal in which they were published. In March 2009, we inaugurated a program to provide Article-Level Metrics (ALM) on every article across all journals. Article-Level Metrics (ALMs) capture the manifold ways in which research is disseminated and can help users determine the value of an article to them and to their scientific community. Read more about Article-Level Metrics.
Visit the Contact page for details about whom to contact with different queries.
PLOS Genetics publication fees are US$2250 per manuscript and will be billed upon acceptance. Authors’ ability to pay publication fees will never be a consideration in the decision whether to publish. Read more about publication fees and publication fee support.
PLOS publishes a suite of influential journals from all areas of science and medicine that contain rigorously reported, peer reviewed Open Access research articles. The journals vary in their criteria for publication and, with the exception of PLOS ONE, also publish a variety of influential and educational non-research content. The journals are editorially independent. Read more about the PLOS suite of journals.